BTIG keeps Buy ratings on four stocks, raises Columbia target
BTIG maintained Buy ratings on Stryker, Merit Medical, Columbia Sportswear and ATI. Columbia's target rose to $83, while ATI's was cut to $250 a share.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at BTIG reaffirmed Buy ratings on four companies at once: Stryker, Merit Medical, Columbia Sportswear and ATI. The information comes from Dow Jones Newswires, citing Benzinga's ratings data.
For Columbia Sportswear, the firm lifted its price target to $83 a share from $80. For ATI, the target was lowered to $250 from $270. The reports on Stryker and Merit Medical mention only that the Buy rating was kept, with no change to price targets.
why it matters
Notes like these are routine analyst updates and usually do not move large-cap shares much. For investors, the direction of target revisions matters more, since it shows how estimates for individual issuers are shifting.
tags
instruments
sources
- Stryker Is Maintained at Buy by BTIG — Dow Jones Newswires, 30 October 2026 at 10:02 UTC
- Merit Medical Is Maintained at Buy by BTIG — Dow Jones Newswires, 30 October 2026 at 10:08 UTC
- Columbia Sportswear Is Maintained at Buy by BTIG — Dow Jones Newswires, 30 October 2026 at 10:05 UTC
- ATI Is Maintained at Buy by BTIG — Dow Jones Newswires, 30 October 2026 at 11:37 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗